Nanoparticle platform enables enhanced delivery of gene therapies
Scientists have created new nanoparticle-based materials that could be used to deliver gene therapies in an adaptable way.
List view / Grid view
Scientists have created new nanoparticle-based materials that could be used to deliver gene therapies in an adaptable way.
Using nanoparticle liposomes, researchers have developed an experimental flu vaccine that has shown success in pre-clinical studies.
Researchers have shown that a protein named aquaporin can disrupt optical development, leading to cataract formation.
Scientists have created an antiviral therapy using lipid nanoparticles that deliver siRNA to the lungs to treat COVID-19 in mice.
Researchers have designed a new nanoparticle-based vaccine against Ebola that has shown promise in mice and rabbits.
Researchers have developed software that can design complex DNA nanodevices which could be used to deliver medicine while in the body.
A team has demonstrated in mouse models that a self-assembling nanofibre material could limit the damage caused by cytokines in inflammatory diseases.
A team has designed gold nanoparticles to reveal specific bone stem cells, which could lead to treatments for major bone fractures.
Recent years have seen an increase in the development of biomaterial and nanoparticle-based vaccine formulations. Sushma Kumari, Sonal Asthana and Kaushik Chatterjee from the Department of Materials Engineering at the Indian Institute of Science discuss why these materials have such high potential in the fight against infectious diseases.
A new delivery vector using platelets has shown success in pre-clinical trials at delivering photothermal particles and immunostimulators to tumours.
A new vaccine formulated with nanoparticles protected animal models from a variety of seasonal and pandemic influenza strains.
A large number of nanorobots in the bladders of mice have been visualised to reveal their movement and behaviour.
Mark Mortenson, CSO of Clene Nanomedicine, discusses the use of proprietary gold nanocrystals as catalysts to prevent the progression of, and act as a treatment for, neurodegenerative disease.
A new nanoparticle-based vaccine has demonstrated success in ferret models of COVID-19, inducing strong neutralising antibodies against SARS-CoV-2.
A team of researchers have used microscopy techniques to monitor DNA degradation and anticancer drug release from nanostructures.